Lupin

Founded by Dr. Desh Bandhu Gupta in 1968, Lupin's culture is driven by the vision of making quality healthcare accessible for all people. The company's central purpose, which it considers its 'North Star', is to catalyze treatments that transform hope into healing for patients everywhere. This purpose is anchored in three core commitments: providing relief from disease, innovating to unlock access at scale, and developing solutions for underserved communities. As a global pharmaceutical leader, Lupin has a strong presence across North America, EMEA, LATAM, APAC, and India, with its products distributed in over 100 markets. Its portfolio includes a wide range of generics, complex generics, specialty medicines, and biosimilars to expand access to quality healthcare for people globally. In its home market, the India business contributed 34% to total revenues in fiscal year 2025, ranking eighth in the Indian Pharmaceutical Market.;